No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Serina Therapeutics Makes Grants to New Employees Under Inducement Plan
Serina Therapeutics Projects Cash and Cash Equivalents and Cash Proceeds From Securities Purchase Agreement to Last Through 3Q
Serina Therapeutics Q1 EPS $(0.49) Beats $(0.61) Estimate
Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
Serina Therapeutics | 8-K: Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
Serina Therapeutics | 10-Q: Q1 2025 Earnings Report